These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 33220323

  • 21. Health-related quality of life is an independent predictor of mortality and hospitalisations in transthyretin amyloid cardiomyopathy: a prospective cohort study.
    Poledniczek M, Kronberger C, Willixhofer R, Ermolaev N, Cherouny B, Dachs TM, Rettl R, Binder-Rodriguez C, Camuz Ligios L, Gregshammer B, Kammerlander AA, Kastner J, Bergler-Klein J, Duca F, Badr Eslam R.
    Qual Life Res; 2024 Oct; 33(10):2743-2753. PubMed ID: 39105960
    [Abstract] [Full Text] [Related]

  • 22. Long-term survival in people with transthyretin amyloid cardiomyopathy who took tafamidis: A Plain Language Summary.
    Elliott P, Drachman BM, Gottlieb SS, Hoffman JE, Hummel SL, Lenihan DJ, Ebede B, Gundapaneni B, Li B, Sultan MB, Shah SJ.
    Future Cardiol; 2023 Jan; 19(1):7-17. PubMed ID: 36715498
    [Abstract] [Full Text] [Related]

  • 23. Health-related quality of life among transthyretin amyloid cardiomyopathy patients.
    Eldhagen P, Lehtonen J, Gude E, Gustafsson F, Bagger-Bahnsen A, Vakevainen M, Pilgaard T, Wedell-Wedellsborg D, Poulsen SH, Nordic PROACT study group.
    ESC Heart Fail; 2023 Jun; 10(3):1871-1882. PubMed ID: 36946241
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Relationship of binding-site occupancy, transthyretin stabilisation and disease modification in patients with tafamidis-treated transthyretin amyloid cardiomyopathy.
    Tess DA, Maurer TS, Li Z, Bulawa C, Fleming J, Moody AT.
    Amyloid; 2023 Jun; 30(2):208-219. PubMed ID: 36399070
    [Abstract] [Full Text] [Related]

  • 27. Natural history and progression of transthyretin amyloid cardiomyopathy: insights from ATTR-ACT.
    Nativi-Nicolau J, Judge DP, Hoffman JE, Gundapaneni B, Keohane D, Sultan MB, Grogan M.
    ESC Heart Fail; 2021 Oct; 8(5):3875-3884. PubMed ID: 34432383
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Improved long-term survival with tafamidis treatment in patients with transthyretin amyloid cardiomyopathy and severe heart failure symptoms.
    Elliott P, Gundapaneni B, Sultan MB, Ines M, Garcia-Pavia P.
    Eur J Heart Fail; 2023 Nov; 25(11):2060-2064. PubMed ID: 37434378
    [Abstract] [Full Text] [Related]

  • 34. Cardiac Biomarker Change at 1 Year After Tafamidis Treatment and Clinical Outcomes in Patients With Transthyretin Amyloid Cardiomyopathy.
    Kuyama N, Takashio S, Oguni T, Yamamoto M, Hirakawa K, Ishii M, Hanatani S, Oda S, Matsuzawa Y, Usuku H, Yamamoto E, Hirai T, Ueda M, Tsujita K.
    J Am Heart Assoc; 2024 May 21; 13(10):e034518. PubMed ID: 38761073
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice.
    Witteles RM, Bokhari S, Damy T, Elliott PM, Falk RH, Fine NM, Gospodinova M, Obici L, Rapezzi C, Garcia-Pavia P.
    JACC Heart Fail; 2019 Aug 21; 7(8):709-716. PubMed ID: 31302046
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Tafamidis: A Review in Transthyretin Amyloidosis with Polyneuropathy.
    Lamb YN, Deeks ED.
    Drugs; 2019 Jun 21; 79(8):863-874. PubMed ID: 31098895
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.